Sanofi (SNY) shareholders
Close on Nov 17, 2026Market cap $115.92BP/E 13.5Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 72,127,649 | 5.80% | 13G (passive) amendment | Mar 31, 2025 |
| Amundi Joint filing with Amundi Asset Management (5.70%) | 68,832,052 | 5.70% | 13G (passive) amendment | Sep 30, 2026 |
| Amundi Asset Management Joint filing with Amundi (5.65%) | 68,651,904 | 5.65% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of SNY | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Dodge & Cox | 28,088,274 | – | $1.20B | −1,416,358 | 0.63% |
| Morgan Stanley | 10,702,527 | – | $456.57M | −1,809,340 | 0.02% |
| Fisher Asset Management, LLC | 10,627,088 | – | $453.35M | −815,075 | 0.13% |
| Bank Of America Corp /De/ | 8,008,572 | – | $341.65M | −1,475,778 | 0.02% |
| Invesco Ltd. | 6,798,961 | – | $290.04M | +177,422 | 0.02% |
| JPMorgan Chase & Co | 6,573,682 | – | $285.50M | +972,951 | 0.02% |
| Mondrian Investment Partners LTD | 5,522,564 | – | $235.59M | +482,499 | 3.63% |
| Brandes Investment Partners, LP | 4,136,417 | – | $176.46M | +413,317 | 1.24% |
| Federated Hermes, Inc. | 3,849,802 | – | $164.23M | −904,557 | 0.24% |
| Boston Partners | 3,844,844 | – | $164.04M | +245,560 | 0.15% |
| Millennium Management LLC | 3,727,890 | – | $159.03M | +287,236 | 0.06% |
| FMR LLC | 3,678,422 | – | $156.92M | −331,739 | 0.01% |
| Envestnet Asset Management Inc | 3,402,765 | – | $145.16M | −459,129 | 0.03% |
| Wells Fargo & Company/Mn | 3,273,820 | – | $139.66M | −141,295 | 0.02% |
| Raymond James Financial Inc | 3,212,810 | – | $137.06M | −599,935 | 0.04% |
| Royal Bank of Canada | 3,170,755 | – | $135.27M | +15,675 | 0.02% |
| Goldman Sachs Group Inc | 2,994,745 | – | $127.76M | +412,289 | 0.01% |
| Barclays PLC | 2,683,902 | – | $114.50M | +327,343 | 0.02% |
| Barrow Hanley Mewhinney & Strauss LLC | 2,680,973 | – | $114.37M | −3,206,493 | 0.35% |
| Regal Partners Ltd | 2,653,974 | – | $113.22M | +108,542 | 6.25% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 715 | 190M | 89 / 213 | 294 / 100 | 14M | 33M |
| Q1 2026 | 745 | 210M | 103 / 303 | 212 / 104 | 37M | 48M |
| Q4 2025 | 757 | 223M | 122 / 247 | 263 / 62 | 17M | 33M |
| Q3 2025 | 712 | 241M | 71 / 254 | 264 / 81 | 23M | 30M |
| Q2 2025 | 731 | 248M | 68 / 282 | 259 / 100 | 16M | 24M |
| Q1 2025 | 774 | 260M | 115 / 308 | 220 / 61 | 24M | 24M |
| Q4 2024 | 732 | 264M | 82 / 251 | 280 / 92 | 24M | 40M |
| Q3 2024 | 758 | 284M | 93 / 294 | 239 / 60 | 36M | 16M |
| Q2 2024 | 730 | 274M | 87 / 322 | 193 / 58 | 30M | 34M |
| Q1 2024 | 711 | 278M | 84 / 297 | 202 / 73 | 36M | 13M |
| Q4 2023 | 709 | 256M | 100 / 198 | 290 / 74 | 23M | 18M |
| Q3 2023 | 697 | 252M | 70 / 271 | 213 / 37 | 13M | 13M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
138 funds held SNY in Q4 2025, 7% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of SNY | Value | % of fund | As of |
|---|---|---|---|---|---|
| Dodge & Cox Stock Fund | 20,904,624 | – | $891.79M | 0.75% | Jun 30, 2026 |
| Invesco Comstock Fund | 4,026,820 | – | $173.48M | 1.16% | Jul 31, 2026 |
| Putnam Focused Large Cap Value ETF | 3,359,654 | – | $146.72M | 1.32% | May 29, 2026 |
| Dodge & Cox Balanced Fund | 1,673,465 | – | $71.39M | 0.48% | Jun 30, 2026 |
| American Mutual Fund | 1,577,744 | – | $67.97M | 0.06% | Jul 31, 2026 |
| Equity Income Fund | 976,561 | – | $41.66M | 0.65% | Jun 30, 2026 |
| Bridge Builder Large Cap Value Fund | 967,100 | – | $41.26M | 0.14% | Jun 30, 2026 |
| VanEck Pharmaceutical ETF | 825,430 | – | $35.21M | 4.00% | Jun 30, 2026 |
| Victory Pioneer Core Equity Fund | 799,487 | – | $34.11M | 1.63% | Jun 30, 2026 |
| First Trust Value Line Dividend Index Fund | 750,187 | – | $32.00M | 0.40% | Jun 30, 2026 |
| Fidelity Enhanced International ETF | 684,151 | – | $29.19M | 0.28% | Jun 30, 2026 |
| Invesco International Dividend AchieversTM ETF | 666,875 | – | $28.73M | 3.10% | Jul 31, 2026 |
| Avantis International Equity ETF | 558,679 | – | $24.40M | 0.14% | May 31, 2026 |
| Invesco Comstock Portfolio | 548,438 | – | $23.40M | 1.20% | Jun 30, 2026 |
| Disciplined Value Global Long/Short Fund | 530,012 | – | $22.61M | 1.75% | Jun 30, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Sanofi's stock actually held short. Settlement fails (shares not delivered on time) peaked at 154,874 shares on Sep 29, 2026 over the last 90 days.
Congress trades
18 trades in Sanofi reported by 10 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Lisa McClain MI09 · spouse | Sold | Sep 11, 2025 | $1K–15K | Oct 22, 2025 |
| Lisa McClain MI09 · spouse | Bought | Aug 4, 2025 | $1K–15K | Sep 12, 2025 |
| Lisa McClain MI09 · spouse | Sold | Jul 22, 2025 | $1K–15K | Aug 13, 2025 |
| Lisa McClain MI09 · spouse | Bought | Jun 17, 2025 | $1K–15K | Aug 13, 2025 57 days late |
| John James MI10 | Sold | Sep 4, 2024 | $1K–15K | Sep 6, 2024 |
| John James MI10 | Bought | Nov 10, 2023 | $1K–15K | Sep 2, 2024 297 days late |
| Daniel Goldman NY10 | Sold | Jul 10, 2023 | $15K–50K | Aug 13, 2023 |
| Daniel Goldman NY10 | Sold (part) | Feb 27, 2023 | $1K–15K | Mar 20, 2023 |
| Earl Blumenauer OR03 · spouse | Bought | May 27, 2022 | $15K–50K | Jul 6, 2022 |
| John Rutherford FL05 | Sold | Mar 16, 2022 | $1K–15K | Apr 19, 2022 |
| Nicholas Van Taylor TX03 · spouse | Sold | Mar 25, 2019 | $15K | Apr 15, 2019 |
| John Rutherford FL05 | Sold | Dec 3, 2018 | $1K–15K | Jan 2, 2019 |
| Kenneth R. Buck CO04 | Sold | Nov 7, 2017 | $1K–15K | Dec 11, 2017 |
| Kenneth R. Buck CO04 | Bought | Oct 27, 2017 | $1K–15K | Nov 2, 2017 |
| Richard L. Hanna NY22 | Sold | Nov 17, 2016 | $100K–250K | Jan 18, 2017 62 days late |
| K. Michael Conaway TX11 · spouse | Sold | Sep 12, 2016 | $1K–15K | Oct 12, 2016 |
| Thomas MacArthur NJ03 · joint account | Sold | Jan 27, 2015 | $15K–50K | Mar 5, 2015 |
| Richard L. Hanna NY22 | Bought | Nov 28, 2014 | $100K–250K | Dec 12, 2014 |
See a number that looks wrong?